Combined administration of aspirin and a specific thrombin inhibitor in man.
BACKGROUND: Heparin is of limited value as an antithrombotic drug in the presence of platelet activation and residual thrombus. Greater anticoagulant activity can be achieved in vivo with more specific thrombin inhibitors. Heparin may also increase the risk of bleeding by an effect on platelets that...
| Glavni autori: | , , , |
|---|---|
| Format: | Journal article |
| Jezik: | English |
| Izdano: |
1991
|